Skip to content
PeptideTech
Cart

Retatrutide vs Survodutide: prices, identity and regulatory status (2026)

Retatrutide and Survodutide are different research compounds, not substitutes for each other: Retatrutide is a single compound (C221H342N46O68); Survodutide is a single compound (C192H289N47O61). Lowest current in-stock prices: Retatrutide 30mg from $199.99 ($6.67/mg) at Amino Club. Retatrutide has no Drugs@FDA application; Survodutide has no Drugs@FDA application.

PTBy PeptideTech EditorsSource timestamps on offersHow we verify →
All products listed are for research purposes only. Not for human consumption.

Retatrutide vs Survodutide: current prices and packages

Compared propertyRetatrutideSurvodutide
CategoryGLP-1GLP-1
Compared package30mg · Vial10mg · Vial
Lowest current price$199.99 at Amino Club, checked Oct 14, 2026No current in-stock price
Price per labelled mg$6.67/mg—
Package sizes5mg, 10mg, 15mg, 20mg, 30mg, 40mg, 48mg, 50mg, 60mg5mg, 6mg, 10mg
Vendors with current prices2 (3 tracked)0 (1 tracked)
Form at this packageVialVial
StockIn stockOut of stock

Prices exclude shipping. The price per labelled mg is always given per mg, so different package sizes compare directly; it is shown only for single-compound vials and powders with a labelled mass. Blends, capsules, liquids and IU-labelled packages are compared by package total.

Identity, regulatory status and registered research

Compared propertyRetatrutideSurvodutide
Molecular formulaC221H342N46O68C192H289N47O61
Molecular weight4731 g/mol4232 g/mol
Sequence——
CAS Registry Number——
Registered clinical trials34 (11 active) · Phase 3: 14, Phase 2: 4, Phase 1: 1527 (9 active) · Phase 3: 11, Phase 2: 3, Phase 1: 13
Human intervention studies76
US regulatory statusNo Drugs@FDA application (checked October 7, 2026) · Drugs@FDA searchNo Drugs@FDA application (checked October 7, 2026) · Drugs@FDA search

Identity data: PubChem, FDA GSRS and EPA records; registry counts: ClinicalTrials.gov; status: Drugs@FDA. A matching name does not verify the contents of a supplier's lot.

Key human studies

Studies are listed as records, newest first; they are not evidence that a research product is safe or effective.

Where to buy each compound

Retatrutide

Retatrutide, also identified as LY3437943, is an investigational agonist at GIP, GLP-1 and glucagon receptors. A peer-reviewed phase 2 trial and a later sponsor-described phase 3 program are different levels of source evidence.

$199.99 · 30mg · $6.67/mg · Amino Club

View at Amino Club, Retatrutide 30mg, opens in a new tabPeptideTech does not sell or fulfill products. Some outgoing links can earn a commission, which does not determine price order. How we rankRetatrutide prices →Price history →

Survodutide

Survodutide is a catalogue entry whose compound-specific reference review has not yet been completed.

No vendor has a current in-stock price for this package.

Survodutide prices →Price history →

Questions

Survodutide has no current in-stock price, so the two cannot be compared on current prices. Current package: Retatrutide 30mg from $199.99 at Amino Club.

Compare another pair

Opens a side-by-side page with current prices, the price per labelled mg where a single-compound mass is listed, sizes, identity data and regulatory status. The products are not interchangeable.

How we verify prices

Automated price sources are scheduled daily; other sources are checked manually. Check the offer's last successful source timestamp. A code is shown when it is attached to an offer or affiliate link. The displayed price includes a discount only when that code is cart-verified and the discounted price is explicitly recorded; otherwise it is the vendor's listed price. Prices exclude shipping. Stock status is captured at the same time. Rankings are by displayed price only. PeptideTech earns a commission when you buy through a link; it never changes the order.

Full method →